Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models

Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models

In the present study, cisplatin, artemisinin, and oleanolic acid were evaluated alone, and in combination, on human ovarian A2780, A2780<sup>ZD0473R</sup>, and A2780<sup>cisR</sup> cancer cell lines, with the aim of overcoming cisplatin resistance and side effects. Cytotoxici...

Full description

Bibliographic Details
Main Authors:	Safiah Ibrahim Althurwi, Jun Q. Yu, Philip Beale, Fazlul Huq
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	International Journal of Molecular Sciences
Subjects:	ovarian cancer drug resistance apoptosis proteomics combination cytotoxicity
Online Access:	https://www.mdpi.com/1422-0067/21/20/7500

Similar Items

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
by: Bo Zhou, et al.
Published: (2019-11-01)

Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
by: Li Liu, et al.
Published: (2019-07-01)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
by: David Schweer, et al.
Published: (2021-01-01)

Enhancement of Cisplatin Sensitivity by Microwave Radiation in Ovarian Cancer Cells
by: Chegeni, N., et al.
Published: (2022)

MALDI-MSI—A Step Forward in Overcoming the Diagnostic Challenges in Ovarian Tumors
by: Dagmara Pietkiewicz, et al.
Published: (2020-10-01)

Identification of Proteins Participating in the Cisplatin Resistance Following Treatment with Cisplatin in A2780 and A2780CP Ovarian Cell Lines
by: Kamyar Keshavarz Farajkhah, et al.
Published: (2020-03-01)

Cytotoxic and Pro-Apoptotic Effects of Honey Bee Venom and Chrysin on Human Ovarian Cancer Cells
by: Elaheh Amini, et al.
Published: (2015-06-01)

Cisplatin Suppresses Proliferation of Ovarian Cancer Cells through Inhibition Akt and Modulation MAPK Pathways
by: Jae-Sun Choi
Published: (2020-03-01)

Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates
by: Shaimaa M. Badr-Eldin, et al.
Published: (2021-02-01)

BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
by: Jinghui Jia, et al.
Published: (2020-08-01)

(−)-Asarinin from the Roots of Asarum sieboldii Induces Apoptotic Cell Death via Caspase Activation in Human Ovarian Cancer Cells
by: Miran Jeong, et al.
Published: (2018-07-01)

COMPARISON OF BLADDER CANCER CELLS APOPTOSIS INDUCED BY METFORMIN, CISPLATIN, AND COMBINATION OF METFORMIN-CISPLATIN: IN VITRO STUDY
by: Arifai Lumbangaol, et al.
Published: (2020-01-01)

Proteomics in the diagnosis of ovarian cancer
by: V. E. Shevchenko, et al.
Published: (2014-07-01)

Goniothalamus lanceolatus extract inhibits the growth of human ovarian cancer cells through migration suppression and apoptosis induction
by: Bihud, N.V, et al.
Published: (2021)

Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice
by: Sook Young Yoon, et al.
Published: (2020-06-01)

Differential analysis of quantitative proteome and acetyl-proteome profiling between premenopausal and postmenopausal ovarian tissues
by: Jinling Yi, et al.
Published: (2018-11-01)

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
by: Andrea Rizzo, et al.
Published: (2021-01-01)

Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells
by: Lin Cheng, et al.
Published: (2020-01-01)

Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers
by: Shuvolina Mukherjee, et al.
Published: (2021-05-01)

Anti-Cancer Activity of a 5-Aminopyrazole Derivative Lead Compound (BC-7) and Potential Synergistic Cytotoxicity with Cisplatin against Human Cervical Cancer Cells
by: Bresler Swanepoel, et al.
Published: (2019-11-01)

N-4-Hydroxyphengl Retinode enhances the killing effect of cisplatin on ovarian cancer cells
by: Guan-Li Xu, et al.
Published: (2016-09-01)

Apoptosis as form of natural ovarian cell death
by: Radovanović Anita M., et al.
Published: (2004-01-01)

Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
by: Yuping Wu, et al.
Published: (2018-09-01)

Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis
by: Nada Abdullah, et al.
Published: (2021-06-01)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
by: Ming-ju Huang, et al.
Published: (2018-02-01)

Caffeic Acid Phenethyl Ester (CAPE) Induced Apoptosis in Serous Ovarian Cancer OV7 Cells by Deregulation of BCL2/BAX Genes
by: Anna Kleczka, et al.
Published: (2020-07-01)

ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
by: Nina Hedemann, et al.
Published: (2021-04-01)

Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion
by: Haixia Wang, et al.
Published: (2018-11-01)

Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer
by: Christen A. Khella, et al.
Published: (2021-02-01)

Chaetomugilin J Enhances Apoptosis in Human Ovarian Cancer A2780 Cells Induced by Cisplatin Through Inhibiting Pink1/Parkin Mediated Mitophagy
by: Hu X, et al.
Published: (2020-10-01)

Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
by: Chia-En Chang, et al.
Published: (2018-01-01)

Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer
by: Bortot B, et al.
Published: (2020-07-01)

Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
by: Kristjansdottir Björg, et al.
Published: (2012-12-01)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
by: Sabine Kasimir-Bauer, et al.
Published: (2020-09-01)

Resistance of Lung Cancer Cells Grown as Multicellular Tumour Spheroids to Zinc Sulfophthalocyanine Photosensitization
by: Sello Lebohang Manoto, et al.
Published: (2015-05-01)

Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity
by: Mahavir Singh, et al.
Published: (2012-09-01)

Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
by: Joohyun Ryu, et al.
Published: (2021-05-01)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019-12-01)

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?
by: Aleksandra Mielczarek-Palacz, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_ar9avsuh7qf09tead8sck9v0i0